EpiDirect® MGMT
Glioblastoma (MGMT promoter methylation)
ApprovedActive
Key Facts
About Pentabase
PentaBase is a private, revenue-generating diagnostics company leveraging its proprietary INA® (Intercalating Nucleic Acid) chemistry to create superior PCR-based assays for oncology. Its core technology enables highly sensitive and specific detection of genetic mutations and methylation patterns, which is critical for cancer diagnostics and monitoring. The company has a portfolio of commercial products, including CE-IVD kits for targets like MGMT and MYD88, and also operates a custom oligonucleotide design and manufacturing business. Headquartered in Copenhagen, Denmark, PentaBase serves a global market through a distributor network.
View full company profile